Ignite Creation Date:
2025-12-24 @ 5:35 PM
Ignite Modification Date:
2026-01-05 @ 7:53 AM
Study NCT ID:
NCT02539368
Status:
COMPLETED
Last Update Posted:
2020-02-13
First Post:
2015-07-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-04-22
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-22
First Submit QC Date:
None
Study First Post Date:
2015-09-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-10-22
Results First Submit QC Date:
None
Results First Post Date:
2020-02-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-30
Last Update Post Date:
2020-02-13
Last Update Post Date Type:
ACTUAL